GDF15 and cardiovascular disorder: In a case-control study of initially healthy women, baseline concentrations of GDF15 were established in 257 women who had a myocardial infarction, stroke, or died from a cardiovascular event during a 4 year follow-up period and in 257 age and smoking status matched women who did not report cardiovascular disease.